; 123 Stat. 2573), as amended by section 722 of the Carl Levin and Howard P. Buck McKeon National Defense Authorization Act for Fiscal Year 2015 ( Public Law 113–291 ), section 723 of the National Defense Authorization Act for Fiscal Year 2016 ( Public Law 114–92 ), and section 741(a) of the National Defense Authorization Act for Fiscal Year 2017 ( Public Law 114–328 ), is further amended by striking September 30, 2018 and inserting September 30, 2019 . 732. Additional emergency uses for medical products to reduce deaths and severity of injuries caused by agents of war Section 1107a of title 10, United States Code, is amended by adding at the end the following new subsection: (d) Additional authority to reduce deaths and severity of injuries caused by agents of war (1) In a case in which an emergency use of an unapproved product or an emergency unapproved use of an approved product cannot be authorized under section 564 of the Federal Food, Drug and Cosmetic Act ( 21 U.S.C. 360bbb–3 ) because the emergency does not involve an actual or threatened attack with a biological, chemical, radiological, or nuclear agent or agents, the Secretary of Defense may authorize an emergency use outside the United States of the product to reduce the number of deaths or the severity of harm to members of the armed forces (or individuals associated with deployed members of the armed forces) caused by a risk or agent of war. (2) Except as otherwise provided in this subsection, an authorization by the Secretary under paragraph (1) shall have the same effect with respect to the armed forces as an emergency use authorization under section 564 of the Federal Food, Drug and Cosmetic Act ( 21 U.S.C. 360bbb–3 ). (3) The Secretary may issue an authorization under paragraph (1) with respect to the emergency use of an unapproved product or the emergency unapproved use of an approved product only if— (A) the committee established under paragraph (5) has recommended that the Secretary issue the authorization